Higher levels of TLR7, an endosomal receptor expressed on dendritic and B cells, which recognizes viral infections and triggers a type I interferon (IFN) response, have been found among women than men, and this provides an advantage in response to COVID-19 [41,42]. This evidence concerns the gene TLR7 and COVID-19.